Epigral Share Price
Sector: Chemical Manufacturing
1810.60 -15.15 (-0.83%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1810.60
Today’s High
1849.00
52 Week Low
1298.80
52 Week High
2408.35
1817.00 -11.10 (-0.61%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1807.70
Today’s High
1860.00
52 Week Low
1299.95
52 Week High
2406.75
Key Metrics
- Market Cap (In Cr) 7818.45
- Beta 1.53
- Div. Yield (%) 0.33
- P/B 4.11
- TTM P/E 22.49
- Peg Ratio 1.84
- Sector P/E 17.59
- D/E 0
- Open Price 1837.55
- Prev Close 1825.75
Epigral Analysis
Price Analysis
-
1 Week2.99%
-
3 Months1.98%
-
6 Month-15.19%
-
YTD-3.59%
-
1 Year38.23%
Risk Meter
- 50% Low risk
- 50% Moderate risk
- 50% Balanced Risk
- 50% High risk
- 50% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 1
- Buy
- 0.00
- 0.00
- 0.00
- 0.00
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 1
- 1
- 1
- 1
Epigral News
Multibagger Stock: Epigral yields 120% return in a year, 430% in over 3 years
1 min read . 18 Nov 2024Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
3 min read . 11 Sep 2024Stocks to buy in May: Nirmal Bang suggests Epigral and Suryoday SFB
3 min read . 07 May 2024Epigral Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 2550.13
- Selling/ General/ Admin Expenses Total
- 114.43
- Depreciation/ Amortization
- 132.56
- Other Operating Expenses Total
- 241.36
- Total Operating Expense
- 1971.92
- Operating Income
- 578.21
- Net Income Before Taxes
- 540.1
- Net Income
- 356.7
- Diluted Normalized EPS
- 83.89
- Period
- 2025
- Total Assets
- 3152.44
- Total Liabilities
- 1247.91
- Total Equity
- 1904.53
- Tangible Book Valueper Share Common Eq
- 437.12
- Period
- 2025
- Cashfrom Operating Activities
- 440.56
- Cashfrom Investing Activities
- -261.56
- Cashfrom Financing Activities
- -163.54
- Net Changein Cash
- 15.46
- Period
- 2024
- Total Revenue
- 1929.19
- Selling/ General/ Admin Expenses Total
- 127.16
- Depreciation/ Amortization
- 123.56
- Other Operating Expenses Total
- 99.19
- Total Operating Expense
- 1570.85
- Operating Income
- 358.34
- Net Income Before Taxes
- 290.75
- Net Income
- 195.87
- Diluted Normalized EPS
- 47.15
- Period
- 2024
- Total Assets
- 2794.34
- Total Liabilities
- 1540.24
- Total Equity
- 1254.1
- Tangible Book Valueper Share Common Eq
- 296.54
- Period
- 2024
- Cashfrom Operating Activities
- 397.64
- Cashfrom Investing Activities
- -401.1
- Cashfrom Financing Activities
- -7.6
- Net Changein Cash
- -11.06
- Period
- 2023
- Total Revenue
- 2188.4
- Selling/ General/ Admin Expenses Total
- 115.66
- Depreciation/ Amortization
- 108.95
- Other Operating Expenses Total
- 90.84
- Total Operating Expense
- 1605.88
- Operating Income
- 582.52
- Net Income Before Taxes
- 522.46
- Net Income
- 353.29
- Diluted Normalized EPS
- 85.03
- Period
- 2023
- Total Assets
- 2432.24
- Total Liabilities
- 1363.14
- Total Equity
- 1069.1
- Tangible Book Valueper Share Common Eq
- 251.24
- Period
- 2023
- Cashfrom Operating Activities
- 626.16
- Cashfrom Investing Activities
- -437.22
- Cashfrom Financing Activities
- -199.79
- Net Changein Cash
- -10.85
- Period
- 2022
- Total Revenue
- 1550.94
- Selling/ General/ Admin Expenses Total
- 94.09
- Depreciation/ Amortization
- 85.91
- Other Operating Expenses Total
- 104.83
- Total Operating Expense
- 1127.29
- Operating Income
- 423.65
- Net Income Before Taxes
- 383.42
- Net Income
- 252.79
- Diluted Normalized EPS
- 60.85
- Period
- 2022
- Total Assets
- 2123.67
- Total Liabilities
- 1397.7
- Total Equity
- 725.97
- Tangible Book Valueper Share Common Eq
- 167.88
- Period
- 2022
- Cashfrom Operating Activities
- 283.82
- Cashfrom Investing Activities
- -454.63
- Cashfrom Financing Activities
- 195.22
- Net Changein Cash
- 24.41
- Period
- 2021
- Total Revenue
- 828.6
- Selling/ General/ Admin Expenses Total
- 58.31
- Depreciation/ Amortization
- 73.54
- Other Operating Expenses Total
- 92.04
- Total Operating Expense
- 640.81
- Operating Income
- 187.79
- Net Income Before Taxes
- 160.86
- Net Income
- 100.84
- Diluted Normalized EPS
- 24.27
- Period
- 2021
- Total Assets
- 1448.75
- Total Liabilities
- 764.62
- Total Equity
- 684.13
- Tangible Book Valueper Share Common Eq
- 157.03
- Period
- 2021
- Cashfrom Operating Activities
- 229.22
- Cashfrom Investing Activities
- -196.73
- Cashfrom Financing Activities
- -31.9
- Net Changein Cash
- 0.58
- Period
- 2020
- Total Revenue
- 610.51
- Selling/ General/ Admin Expenses Total
- 48.54
- Depreciation/ Amortization
- 44.3
- Other Operating Expenses Total
- 64.02
- Total Operating Expense
- 460.25
- Operating Income
- 150.25
- Net Income Before Taxes
- 140.99
- Net Income
- 112
- Diluted Normalized EPS
- 26.96
- Period
- 2020
- Total Assets
- 1273.46
- Total Liabilities
- 689.99
- Total Equity
- 583.47
- Tangible Book Valueper Share Common Eq
- 140.43
- Period
- 2020
- Cashfrom Operating Activities
- 164.68
- Cashfrom Investing Activities
- -363.21
- Cashfrom Financing Activities
- 69.41
- Net Changein Cash
- -129.12
- Period
- 2025-03-31
- Total Revenue
- 627.63
- Selling/ General/ Admin Expenses Total
- 31
- Depreciation/ Amortization
- 33.95
- Other Operating Expenses Total
- 56.63
- Total Operating Expense
- 488.2
- Operating Income
- 139.43
- Net Income Before Taxes
- 130.34
- Net Income
- 85.9
- Diluted Normalized EPS
- 20.16
- Period
- 2025-03-31
- Total Assets
- 3152.44
- Total Liabilities
- 1247.91
- Total Equity
- 1904.53
- Tangible Book Valueper Share Common Eq
- 437.12
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 440.56
- Cashfrom Investing Activities
- -261.56
- Cashfrom Financing Activities
- -163.54
- Net Changein Cash
- 15.46
- Period
- 2024-12-31
- Total Revenue
- 645.24
- Selling/ General/ Admin Expenses Total
- 29.09
- Depreciation/ Amortization
- 32.91
- Other Operating Expenses Total
- 70.11
- Total Operating Expense
- 495.64
- Operating Income
- 149.6
- Net Income Before Taxes
- 153.62
- Net Income
- 103.63
- Diluted Normalized EPS
- 24.25
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 626.06
- Selling/ General/ Admin Expenses Total
- 26.99
- Depreciation/ Amortization
- 32.25
- Other Operating Expenses Total
- 56.88
- Total Operating Expense
- 479.88
- Operating Income
- 146.18
- Net Income Before Taxes
- 125.18
- Net Income
- 81.3
- Diluted Normalized EPS
- 19.57
- Period
- 2024-09-30
- Total Assets
- 2979.45
- Total Liabilities
- 1579.19
- Total Equity
- 1400.26
- Tangible Book Valueper Share Common Eq
- 332.11
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 218.48
- Cashfrom Investing Activities
- -84.95
- Cashfrom Financing Activities
- -134.61
- Net Changein Cash
- -1.08
- Period
- 2024-06-30
- Total Revenue
- 651.2
- Selling/ General/ Admin Expenses Total
- 27.4
- Depreciation/ Amortization
- 33.45
- Other Operating Expenses Total
- 57.74
- Total Operating Expense
- 508.25
- Operating Income
- 142.95
- Net Income Before Taxes
- 130.96
- Net Income
- 85.87
- Diluted Normalized EPS
- 20.67
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 524.63
- Selling/ General/ Admin Expenses Total
- 25.52
- Depreciation/ Amortization
- 30.38
- Other Operating Expenses Total
- 49.02
- Total Operating Expense
- 399.67
- Operating Income
- 124.97
- Net Income Before Taxes
- 113.46
- Net Income
- 77.28
- Diluted Normalized EPS
- 18.6
- Period
- 2024-03-31
- Total Assets
- 2794.34
- Total Liabilities
- 1540.24
- Total Equity
- 1254.1
- Tangible Book Valueper Share Common Eq
- 296.54
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 397.64
- Cashfrom Investing Activities
- -401.1
- Cashfrom Financing Activities
- -7.6
- Net Changein Cash
- -11.06
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Epigral Technical
Moving Average
SMA
- 5 Day1799.3
- 10 Day1794.56
- 20 Day1833
- 50 Day1831.5
- 100 Day1810.68
- 300 Day1919.32
Epigral Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Gujarat State Fertilizers And Ch
- 207.25
- -4.4
- -2.08
- 274.5
- 156.5
- 8258.45
- Gujarat Narmada Valley Fert Chem
- 541.15
- -11.25
- -2.04
- 776.6
- 448.9
- 7948.09
- Epigral
- 1810.6
- -15.15
- -0.83
- 2408.35
- 1298.8
- 7818.45
- Dhanuka Agritech
- 1666.2
- -29.95
- -1.77
- 1926.4
- 1091.6
- 7562.9
- Sharda Cropchem
- 813.2
- -9.5
- -1.15
- 886.35
- 411.8
- 7336.73
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Gujarat State Fertilizers And Ch
- 14.17
- 0.69
- 6.82
- 8.06
- Gujarat Narmada Valley Fert Chem
- 13.6
- 0.95
- 12.95
- 12.37
- Epigral
- 21.65
- 4.11
- 25.32
- 13.92
- Dhanuka Agritech
- 25.78
- 5.43
- 23.18
- 14.22
- Sharda Cropchem
- 23.86
- 2.9
- 12.63
- 7.18
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 05-May-25
- Audited Results & Final Dividend
- 27-Jan-25
- Quarterly Results & Interim Dividend
- 09-Nov-24
- Quarterly Results
- 14-Aug-24
- To consider Fund Raising
- 24-Jul-24
- Quarterly Results
- 22-Apr-24
- Audited Results & Final Dividend
- 24-Jan-24
- Quarterly Results
- 06-Nov-23
- Quarterly Results
- 05-Aug-23
- Quarterly Results
- 25-Apr-23
- Audited Results & Final Dividend
- Meeting Date
- Announced on
- Purpose
- 28-Jun-25
- 05-Jun-25
- AGM
- 19-May-25
- 15-Apr-25
- POM
- 18-Sept-24
- 19-Aug-24
- POM
- 09-Jul-24
- 12-Jun-24
- AGM
- 29-Jul-23
- 27-Jun-23
- POM
- 27-Jun-23
- 05-Jun-23
- AGM
- 14-Mar-22
- 11-Feb-22
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 05-May-25
- -
- -
- 3.5
- 27-Jan-25
- 07-Feb-25
- 07-Feb-25
- 2.5
- 22-Apr-24
- 02-Jul-24
- 02-Jul-24
- 5
- 25-Apr-23
- 20-Jun-23
- 20-Jun-23
- 2.5
- 19-Jan-23
- 01-Feb-23
- 01-Feb-23
- 2.5


